你即將離開本站

並前往https://www.clinicaltrialsarena.com/projects/rimonabant/

Investigational Agent for the Management of Obesity - Clinical ...

Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective CB1 endocannabinoid receptor antagonist indicated for the treatment of obesity.

確定！ 回上一頁

查詢 「Antagonist」的人也找了：

  1. antagonist醫學中文
    2.
  2. antagonists中文
    3.
  3. antagonist拮抗劑
    4.
  4. antagonist藥理
    5.
  5. antagonist字根
    6.
  6. Antagonistic
    7.
  7. competitive antagonist中文
    8.
  8. Receptor antagonist
    9.